By EH News Bureau on February 9, 2021 International Harmonising of the standards and specifications will boost the Medical devices Industry in India: Dr P B N Prasad The government is focusing on the Harmonising the devices, policy framework, quality management system, harmonising and creative a conducive system for the manufacturer Happening Now News The missing informal workers in India’s vaccine story Read Article WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Share Health and Pharmaceutical Manufacturing and Medical Devices Committee, PHDCCI in association with Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India organised third series of Self Sufficiency in Medical Technology on “India to be an attractive destination for MedTech”.The guest of honour of the session was Dr P B N Prasad, Joint Drugs Controller General of India, CDSCO. In his remarks he said that the regulator is the last part of the system. In the next decade India should be a medical devices hub and to make that possible, the government is focusing on the Harmonising the devices, policy framework, quality management system, harmonising and creative a conducive system for the manufacturer.He further mentioned that regulators are also facing several technical challenges now a day, country is dependent on imports in this sector and there is a need for becoming Aatmanirbhar in this domain by reducing the dependency of imports and facilitating the home manufacturers.Dr Prasad also encouraged for India to be a medical manufacturing hub including generics and medical devices both. He further said that India has large pool of engineers and pharmacists and COVID-19 has made us learnt many lessons in this sector.He said that we need a robust ecosystem and we have high hopes that all challenges will be overcome within the decade itself. Right now regulators, investors and manufacturers are all in learning and evolving process. As necessity is the mother of the invention, Medical device industry will be a great boon for the country in the coming years.He further mentioned that we do have the skilled manpower and now we need to have innovation in R&D and innovation hub as today it is the necessity to innovate, manufacture and become self reliant in the medical devices.The webinar was also attended by Pradeep Multani, Sr Vice President, PHDCCI, Dr N Subramanian, Chair, Health Committee, PHDCCI & Director, Medical Services, Indraprastha Apollo Hospitals and Bhargav Kotadia, Co-Chair, Pharmaceutical Manufacturing & Medical Devices Committee, PHDCCI & Managing Director, Sahajanand Medical Technologies.The other eminent panelists present were Pavan Choudary, DG and Chairman, MTaI and Managing Director, Vygon India, Nitin Mahajan, Director, J MItra and Co, Gaurav Agarwal, Managing Director, IITPL and Akriti Bajaj, Senior Manager / Healthcare Lead at Invest IndiaWhile giving the welcome remarks, Multani said that the healthcare sector in India has rapidly progressed in the last decade. Today, the country is favorably positioned in the medical devices domain for outsourced contract design, development, and manufacturing. The focus on design-to-cost and a robust manufacturing ecosystem makes India a suitable destination for design-led-manufacturing of medical devices.Multani also mentioned about the five main reasons for India as fast emerging ideal base for medical equipment manufacturing like Presence of skilled resources, various Government initiatives like PLI Schemes, Medical technology parks and support to the MedTech industry, Cost-effective operations, Sensitivity to Intellectual Property rights and data security and last one as Robust ecosystem to support production.Dr N Subramanian mentioned that technology advancement is making healthcare affordable, accessible and available to larger population. He further mentioned that risk of people dying from non-communicable diseases are raising and expenditure of more than 30 trillion will be there on treating such diseases if not prevented early. Prevention, early diagnosis and curative treatment are the points to be focused moving forward. He also mentioned that today we are so much of technology dependent but technology also comes at a cost. The MedTech industry in India should hold the path of innovation so that its products and solutions are custom-designed for the opportunities and constraints of the country.Bhargav Kotadia said that the COVID-19 pandemic has presented a unique opportunity for India to emerge as the new manufacturing hub of the world. With India now taking centre stage in the fight against COVID, India’s MedTech sector is slated for a global presence which positions India as a global hub for medical devices. Further, post the Union Budget 2021, it is now clear that MedTech will be the next sunshine industry. Last two decades have seen many disruptive technologies in various industries, but the highly regulated market of medical devices was a dampener. Today, with more conducive policies announced in the healthcare and MedTech sector, especially sector specific reforms such as the PLI Scheme, making of Bulk, API, Medical Device parks and the “Atmanirbhar Bharat” approach by the government, will surely help the sector thrive and be resilient during this pandemic period.This offers the medical device industry the opportunity to leapfrog and make fundamental and sweeping changes that will sustain for years to come, for both domestic and global players, making India a truly attractive destination.Pavan Choudary said that our goal should be to capitalise on our strengths, while we build new ones. First, we should try to avoid bringing in policies that could destabilise the trend of rising FDI in MedTech that we are receiving, and channelise it towards existing manufacturers, dependable budding manufacturers and component manufacturers to form Joint Ventures and collaborations. Second, we should also build upon our Healthcare Worker Training capacities with collaborations between global innovators, local companies and the government.Third, India is the third largest employer of R&D in MedTech (After US and Germany). The R&D specific investment of Rs 1200 crore by Medtronic just last year is another testimony to the fact that we have immense potential in R&D in MedTech, and we should try to tap it.Gaurav Agarwal emphasised that India is among the fastest growing medical devices in the world and yet we are only under two per cent of the global market and heavily import dependent. We need to do the full to make India an attractive destination for MedTech.Agarwal also emphasised on some points to look after like need of a predictable regulatory roadmap, nominal protective tariff barriers in areas of high import dependence, R&D ecosystem by bringing Academia, funding agencies together in incubators and Phased Manufacturing Program (PMP) by gradually increasing customs duties in finished goods in key areas.Nitin Mahajan said that by another 15 years, we would find India to be more affluent and technology will support things for being accessible. Furthermore, technology would aid manufacturing by making production quicker. Technology will be at a cost, however what India needs is technology with sustainable costs-hence making in India is a long term solution and Atmanirbhar is in right spirit. High end technology being 90 per cent imported needs to be looked into as this is the biggest need and also the opportunity zone.Mahajan further mentioned that COVID has accelerated the need for improvement in both healthcare plus education. The Government in its budget are focusing on both by increase in spend and maximising use of digital tech to connect. There are three axis approach for India Movement; first being manufacturing as in manufacturing, there has to be an entry barrier in the form of import duty else its easy to make in any part of the world (and claim export incentive) and import the same in NIL-duty much to loss of domestic manufacturer. Normally, each country has its own protection tariff structure in place; second being approvals for Licensing, Testing Labs, Certifications as Medial Device- Does not need Sampling, testing and approvals, as like Pharma. Also the limited number tesing labs creates delay and loss of opportunity and we should not limit to international CE/US FDA, which most Indian makers do not aim for and lastly third being the market acceptance as Indian makers, need domestic demand to sustain, else all efforts are in vain.Akriti Bajaj, Healthcare and Medical devices lead at Invest India, the national investment promotion agency of India mentioned the government’s various initiatives to achieve this goal, such as the launch of Production linked incentives 1.0 and 2.0. Related Posts MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Phoenix Business Consulting invests in telehealth platform Healpha Akriti BajajDr. P B N PrasadIndia to be an attractive destination for MedTechmedical devicemedtech Adoption of AI/ML can disrupt healthcare services Menopause to become the next game-changer in global femtech solutions industry by 2025 Comments (0) Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Add Comment
RelatedOPM State Minister to Manage National Recovery Effort RelatedOPM State Minister to Manage National Recovery Effort FacebookTwitterWhatsAppEmail Minister of State in the Office of the Prime Minister, Hon. Luther Buchanan, is to coordinate the Government’s hurricane recovery and relief programme. This was disclosed by Prime Minister, the Most Hon. Portia Simpson Miller, during a statement on Tuesday (Nov. 6) to the House of Representatives. Mrs. Simpson Miller explained that Mr. Buchanan will work along with the Office of Disaster Preparedness and Emergency Management (ODPEM) to ensure speedy and impartial implementation of the Government’s efforts. He will also ensure effective coordination and prioritisation of the recovery and reconstruction activities within the Ministries, Departments and Agencies for a period not exceeding six months. “The Government will communicate with the public to provide updates on the status of recovery programmes through the six-month period,” Mrs. Simpson Miller said. In the meantime, the Government has already received commitments of support from the French Government for the health and education sectors; and the Government of Germany for the education sector. The Government of Japan has also pledged assistance to the College of Agriculture Science and Education (CASE) in Portland; and the Annotto Bay Hospital in St. Mary. Financial support is also coming from the Caribbean Disaster Emergency Management Agency (CDEMA) through the Brazil/CARICOM Initiative, and the Caribbean Development Bank (CDB) for support to the health sector. ODPEM is also coordinating the efforts of several non-governmental organisations that are garnering funding to assist the national reconstruction efforts. RelatedOPM State Minister to Manage National Recovery Effort OPM State Minister to Manage National Recovery Effort EnvironmentNovember 8, 2012 Advertisements
iStock/Thinkstock(HOLLYWOOD, Md.) — Friends and family of 16-year-old Jaelynn Willey have gathered at her funeral service Friday morning after the teen was gunned down at her Maryland high school.On March 20, Willey was in a hallway at Great Mills High School when she was shot once in the head, allegedly by 17-year-old Austin Rollins, the St. Mary’s County Sheriff’s Office said. A 14-year-old boy was also injured in the leg from the shooting.Rollins was confronted by a school resource officer and fatally shot himself in the head, the sheriff’s office said.Two days after the shooting, Willey’s mother tearfully announced her daughter would be taken off life support. Willey, the second-oldest of nine siblings, died hours later, surrounded by her family, the sheriff’s office said.Friday’s funeral began at 10 a.m. at the Hollywood Volunteer Fire Department in Hollywood, Maryland. Maryland Gov. Larry Hogan is among those at the service, according to ABC affiliate WJLA-TV.A prayer service was also held there on Thursday.Michelle Morren, whose daughter was friends with Willey, told The Baltimore Sun after the prayer service, “Everyone who ever came in contact with Jaelynn walked away thinking, ‘Wow, that was a beautiful soul.’”Everyone at the service was given a card with Willey’s “best ever” recipe for chocolate chip cookies, the Sun reported.Copyright © 2018, ABC Radio. All rights reserved.
On the eve of Election Day, the United States is entering uncharted territory in the COVID-19 pandemic.According to the Johns Hopkins COVID-19 dashboard, the nation reported 81,493 new COVID-19 cases yesterday and 447 deaths, two days after nearly hitting 100,000 new infections. The 7-day average of new daily infections is higher than 81,000, according to a CNBC analysis of the Johns Hopkins data.And those numbers could be an undercount. Public health officials told the New York Times they’re worried that because several states don’t report the results of rapid COVID-19 antigen testing, there could be greater spread of the virus than is being reported. The paper reports that seven states plus Washington, DC, don’t publicly report antigen test results, while six keep the number separate from their total case count.COVID Tracking Project data, meanwhile, show the 7-day average for COVID-hospitalizations at 45,690, which is below the levels seen in the spring and summer peaks but is steadily climbing as states across the country see their hospitals filling up with COVID-19 patients.There have been 9,268,896 confirmed COVID-19 cases since the pandemic began in the United States, and 231,353 deaths, according to the Johns Hopkins tracker.COVID-19 shadow on the campaign trailAmid the nationwide surge in cases, President Donald Trump and Democratic presidential candidate Joe Biden are crisscrossing the country in their last full day of campaigning, presenting starkly different message on the pandemic.While Biden has promoted the wearing of masks, warned of a dark winter, and said he will listen to the scientists, Trump has downplayed and sometimes mocked masks, criticized coronavirus restrictions, and repeatedly said the country is turning the corner even as COVID-19 cases rise. And at a rally in Florida yesterday, the president suggested he might fire Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases and member of the White House coronavirus task force, if he wins the election.”Don’t tell anybody, but let me wait until a little bit after the election,” Trump said in response to “fire Fauci” chants from the crowd, according to the Associated Press.The remark came in the wake of an interview in which Fauci told the Washington Post that that the country “could not possibly be positioned more poorly” heading into the winter, and needed to make an “abrupt change” in its approach to the pandemic. Fauci also said that the Biden campaign is looking at the pandemic from a public health perspective, while the Trump administration is more focused on the economy.Surveys suggest the electorate’s views of the pandemic is closer to the former vice president’s. In an NBC News/Wall Street Journal poll released yesterday, 55% of respondents said they think the worst is yet to come with the pandemic, compared with 25% who said the worst is behind us. A Pew Research poll from earlier in the month found that 57% of registered voters were confident that Biden could handle the pandemic, compared with 40% for Trump.New restrictions in MassachusettsIn other US developments:Massachusetts Gov Charlie Baker imposed new COVID-19 restrictions today, ordering residents to remain home from 10:00 pm to 5:00 am and requiring masks in public for anyone over the age of 5, WBUR reports. Venues such as theaters and casinos must close at 9:30 pm every night, and restaurants must stop table service at that time. Baker said new daily COVID-19 cases in the state have risen by almost 300% since Labor Day, and hospitalizations are up 145%. The restrictions begin on Nov 6.New York Gov Andrew Cuomo announced over the weekend that the state would start requiring incoming travelers to take a COVID-19 test 4 days before arriving and 4 days after entering the state. The order replaces the state’s quarantine list, which had required travelers from US hot spots to quarantine for 14 days after arrival.A Stat News investigation found that the Department of Health and Human Services (HHS) relaxed oversight of laboratory-developed COVID-19 tests in mid-August, despite reports that the tests had quality issues. Dozens of these tests are being used by states, universities, businesses, and sports leagues, but their accuracy is unknown because HHS directed the Food and Drug Administration to stop requiring emergency use authorization.
It celebrates City’s past yet lines up with the new era as City head into the 2019/20 season with a firm identity under the much-loved robin.The programme is a smaller size to make it easier to carry around, yet boasts more pages and new content than Well Red. Supporters can still hear from Lee Johnson and Mark Ashton, as well as enjoy a new column from club captain Bailey Wright.As well as a look at the opposition, the City squad will be revealing their world XI and the number of history pages have been increased. Throughout the season, David Woods and Mike Adams will tell the story of the club’s history and there is a page dedicated to supporters’ stories and memories.Augmented Reality also returns this season bring the programme ‘to life’. It enables supporters with the official Bristol City app to scan pages – look out for the AR logo – with the app’s AR camera mode.WHERE TO BUY YOUR MATCHDAY PROGRAMMEThe programme is on sale around the ground at the following locations:Fans Village aside the Atyeo StatueAshton Road (Dolman entrance)Ashton Road (Lansdown entrance)South Stand behind turnstilesFind all this and more inside The Robins Matchday Programme, available for £3.50.